Celltrion chief embarks on global tour to accelerate overseas sales The Korea Times 05:09 Wed, 05 Aug
Celltrion expands US PBM coverage for follow-on biosimilars Korea Biomedical Review 07:19 Mon, 03 Aug
Celltrion widens Omlyclo contracts in Italy as new biosimilars gain traction Korea Biomedical Review 07:31 Fri, 31 Jul
Celltrion to unveil obesity drug data this year, first ADC clinical readouts in 2027 Korea Biomedical Review 02:33 Wed, 29 Jul
Celltrion's Q2 profit jumps 86% on biosimilar growth, stronger margins Korea Biomedical Review 03:01 Mon, 27 Jul
Celltrion Q2 net profit jumps nearly sixfold on strong biosimilar sales Yonhap News Agency 01:50 Mon, 27 Jul
Celltrion files for European approval of Cosentyx biosimilar CT-P55, accelerating push into key global markets Korea Biomedical Review 06:57 Fri, 24 Jul
Celltrion wins Korea phase 1 approval for Tremfya biosimilar Korea Biomedical Review 07:47 Wed, 15 Jul
Celltrion gets green light for Phase 1 clinical trial of 'Tremfya' biosimilar in South Korea Asia Today 02:00 Wed, 15 Jul
Celltrion’s Truxima® Approved as First Interchangeable Rituxan® Biosimilar JD Supra 20:18 Tue, 14 Jul
Celltrion licenses autoimmune disease antibody technology from Catholic University Korea Biomedical Review 02:37 Tue, 14 Jul
Celltrion and Teva’s TRUXIMA® Becomes First Interchangeable Rituximab Biosimilar in U.S. JD Supra 17:14 Fri, 10 Jul
